SCHEMBL10051169

SCHEMBL10051169

COc1cc(C)c(I)c(OC)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 2/20 0.44
ALDH1A1 P00352 4/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
CYP19A1 P11511 1/20 0.42
HPGD P15428 2/20 0.41
LMNA P02545 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CYP3A4 P08684 5/20 0.39
CYP1A2 P05177 4/20 0.39
CYP1A1 P04798 2/20 0.38
CYP1B1 Q16678 2/20 0.38
USP2 O75604 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL504691 0.85 ALDH1A1 (0.53) NQO2ALDH1A1CA12CA1CA2
SCHEMBL282134 0.85 ALDH1A1 (0.53) NQO2ALDH1A1CA12CA1CA2
SCHEMBL24327418 0.79 ACHE (0.36) NQO2ALDH1A1CA12CA1CA2
SCHEMBL30833916 0.79 ACHE (0.52) ALDH1A1KDM4ECYP3A4SMN1; SMN2ERN1
SCHEMBL17924627 0.77 ALDH1A1 (0.43) NQO2ALDH1A1CA12CA1CA2
SCHEMBL12141429 0.76 ALDH1A1 (0.48) NQO2ALDH1A1CA12CA1CA2
SCHEMBL15120000 0.76 ALDH1A1 (0.52) NQO2ALDH1A1CA12CA1CA2
SCHEMBL26093189 0.76 CYP3A4 (0.58) ALDH1A1CA1CA2HPGDKDM4E
SCHEMBL1425712 0.76 ALDH1A1 (0.42) NQO2ALDH1A1CA12CA1CA2
SCHEMBL30412068 0.76 FFAR4 (0.34) NQO2ALDH1A1CYP19A1LMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9273021-B2 Dibenzofuran derivatives as inhibitors of fructose 1,6-bisphosphatase and methods of use thereof TRUSTEES OF BOSTON COLLEGE (US) 2016-03-01 US disclosed
US-20120028892-A1 INHIBITORS OF FRUCTOSE 1,6-BISPHOSPHATASE AND METHODS OF USE THEREOF TRUSTEES OF BOSTON COLLEGE (US) 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028892-A1 INHIBITORS OF FRUCTOSE 1,6-BISPHOSPHATASE AND METHODS OF USE THEREOF FBP1, SLC5A1, ALDOA NQO2 248/4885ALDH1A1 279/4885CA12 1610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.